S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
Biden’s $374B Giveaway Into This Sector (Ad)
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
Biden’s $374B Giveaway Into This Sector (Ad)
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
Biden’s $374B Giveaway Into This Sector (Ad)
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
Biden’s $374B Giveaway Into This Sector (Ad)
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:OCAT

Ocata Therapeutics (OCAT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free OCAT Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$8.47
▼
$8.47
50-Day Range
N/A
52-Week Range
$3.06
▼
$8.71
Volume
N/A
Average Volume
656,469 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
OCAT stock logo

About Ocata Therapeutics Stock (NASDAQ:OCAT)

Ocata Therapeutics, Inc., formerly Advanced Cell Technology, Inc., is a biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. The Company's advanced products are in clinical trials for the treatment of Stargardt's macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. The Company is also developing several pre-clinical terminally differentiated-cell therapies for the treatment of other ocular disorders. Additionally, it has a number of pre-clinical stage assets in disease areas outside the field of ophthalmology, including autoimmune, inflammatory and wound healing-related disorders.

OCAT Stock News Headlines

May 6, 2023 | marketwatch.com
Human Embryonic Stem Cells Market Latest Trends, Demand and Precise Outlook- Orthofix International N.V., Sumanas, Ocata Therapeutics
May 3, 2023 | marketwatch.com
Tooth Regeneration Market Emerging Trends till 2031
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
April 29, 2023 | marketwatch.com
Global Tooth Regeneration Market by [2023-2029] with Revenue Outsourcing
March 27, 2023 | marketwatch.com
Induced Pluripotent Stem Cells Market by 2031
March 8, 2023 | finance.yahoo.com
Combined Therapeutics Expands Board of Directors with Appointments of Biopharma Industry Veterans Paul Wotton, Robert Ruffolo and Kevin F. McLaughlin
March 6, 2023 | marketwatch.com
Tooth Regeneration Market is Booming Worldwide to Show Significant Growth over the Forecast 2023 to 2028
February 25, 2023 | marketwatch.com
Tooth Regeneration Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 22, 2023 | marketwatch.com
Tooth Regeneration Market Booming With Rising Demands and Massive Opportunities, 2023 - 2028
February 15, 2023 | marketwatch.com
Tooth Regeneration Market: What Strategies Do Companies to Increase Industry Share and Revenue Source?
February 8, 2023 | marketwatch.com
Tooth Regeneration Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2028
January 11, 2023 | marketwatch.com
Tooth Regeneration Market 2023 : Future Trend, Business Strategies, Comprehensive Analysis and Forecast by 2028
December 22, 2022 | marketwatch.com
With 3.8% CAGR, Tooth Regeneration Market 2023-2028 Find Out Essential Strategies To Expand The Business And Top Key Players | 88 Pages Report
December 10, 2022 | marketwatch.com
Tooth Regeneration Market Grows Massively, with Industry Entry Investment Feasibility, and Report Conclusion to 2028 | No. 92 Data Insights
November 24, 2022 | marketwatch.com
Epithelial Stem Cells (Escs) Market Size 2022 Global Analysis Report by Share, Latest Trends, Market Dynamics and Forecast to 2026
July 30, 2022 | marketwatch.com
Human Embryonic Stem Cells Market Share, Future Demand, Dynamics, Drivers, Research Methodology by 2026
June 9, 2022 | investing.com
Binh Duong Water Environment JSC (BWE)
June 9, 2022 | investing.com
Trias Sentosa Tbk (TRST)
June 9, 2022 | investing.com
Hanyang Eng Co Ltd (045100)
June 9, 2022 | investing.com
Indo Acidatama Tbk (SRSN)
April 13, 2022 | marketwatch.com
Tooth Regeneration Market Size 2022 Analysis by Competitive Landscape, Key Players, Growth Opportunities, Share and Forecast to 2024 Research Report
October 21, 2021 | investing.com
Ocata Therapeutics Inc (OCAT)
September 1, 2021 | marketwatch.com
Human Embryonic Stem Cells Market Size, Future Trends, Industry Share, Growth Prospects, Key Players, Market Segments and Forecast 2021-2026
See More Headlines
Receive OCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/06/2015
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:OCAT
Previous Symbol
OTCMKTS:ACTC
CUSIP
N/A
CIK
1140098
Web
www.ocata.com
Phone
+1-508-7561212
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

OCAT Stock Analysis - Frequently Asked Questions

How were Ocata Therapeutics' earnings last quarter?

Ocata Therapeutics (NASDAQ:OCAT) released its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.01. The biotechnology company had revenue of $0.04 million for the quarter.

What other stocks do shareholders of Ocata Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ocata Therapeutics investors own include Antares Pharma (ATRS), Anavex Life Sciences (AVXL), Sarepta Therapeutics (SRPT), Prospect Capital (PSEC), Conatus Pharmaceuticals (CNAT), Geron (GERN), Athersys (ATHX), Cytori Therapeutics (CYTX), Microbot Medical (MBOT) and Nektar Therapeutics (NKTR).

This page (NASDAQ:OCAT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace